Announcements
Welcome message
We are pleased to announce the Kyoto Breast Cancer Consensus Conference (KBCCC) 2026 International Meeting.
Since 2007, the Kyoto Breast Cancer Consensus Conference (KBCCC) has continuously convened regular domestic meetings, fostering in-depth discussions among experts on key clinical issues in breast cancer care. In 2009, the first international meeting was held, bringing together researchers and clinicians from around the world and establishing KBCCC as an important international forum for building consensus on the diagnosis and treatment of breast cancer.
The KBCCC 2026 International Meeting will be held over two days, on Friday, April 10, and Saturday, April 11, 2026, at the Kyoto International Conference Center, in a hybrid format combining onsite and online participation.
The primary objective of this conference is to build consensus in breast cancer care and thereby contribute to improved quality of life and better treatment outcomes for patients. Beyond what is addressed in clinical guidelines and major international conferences, this meeting aims to focus on real-world clinical decision-making that cannot be resolved by evidence alone. By integrating the collective wisdom of experts, sharing insights openly, and consolidating outcomes as the KBCCC group, we seek to disseminate internationally relevant standards from Kyoto.
The main theme of the meeting is "Precision in Motion: Elevating, Easing, Evolving." The scientific program will include invited lectures, panel discussions, consensus sessions, and poster presentations. Lively discussions are planned on clinically relevant topics such as local therapy, neoadjuvant treatment, escalation strategies for luminal breast cancer, biomarkers, and prevention and risk management.
We hope that this meeting will provide an invaluable opportunity for all professionals involved in breast cancer care to share the latest knowledge and apply it to daily clinical practice. We sincerely look forward to welcoming many participants to Kyoto.
Kyoto Breast Cancer Consensus Conference 2026
Representative Organizer
Norikazu Masuda, Professor, Department of Breast Surgery
Graduate School of Medicine, Kyoto University
Organizer
Masahiro Takada, Professor and Chair, Department of Breast Surgery
Kansai Medical University
Organizer
Kosuke Kawaguchi, Professor, Breast Center
Mie University Hospital
Overview
• Advances in Axillary Management of Breast Cancer: Optimization and De-escalation
• Neoadjuvant Therapy and Local Treatment
• Luminal Breast Cancer: Treatment Escalation
• Biomarker
• Reimagining the Future: A New Era of Breast Cancer Screening and Risk Prediction
(subject to change)
Program
Faculty member
Confirmed international guests :
Professor of Surgery
Dale H Dorn Endowed Chair in Surgery
University of Texas San Antonio
Consultant Surgeon, Addenbrooke's Hospital Cambridge CB2 0QQ
Affiliated Assistant Professor, University of Cambridge
Visiting Professor, School of Medicine, Anglia Ruskin University, Cambridge CB1 1PT
Formerly Honorary Secretary, Association of Breast Surgery
Confirmed domestic guests :
Chief of Breast Surgery
Registration
Registration is processed through Peatix, an external ticketing platform.
Registration Fees
| General | JPY 20,000 | Participants who do not fall into any of the categories below |
| Member | JPY 15,000 | Japanese Breast Cancer Society / KBCRN members |
| Fellows / Residents / Students | JPY 5,000 | |
| Patient Advocacy Group Members | JPY 5,000 | |
| Co-sponsored Seminar Companies | Free | Up to 3 people per company (No Peatix registration required) |
| Invited Speakers | Free | Please do not register via this page |
Early Registration Deadline
Friday, March 27, 2026, 12:00 noon (JST)
On-site registration will be available, but does not include meals.
Supporters
Special Cooperation
Japanese Breast Cancer Society
Seminar Sponsor
- CHUGAI PHARMACEUTICAL CO.,LTD
- Exact Sciences K.K.
- Guardant Health Japan Corp.
- Daiichi-Sankyo Co., Ltd.
- MSD K.K
- Pfizer Japan Inc.
- Eli Lilly Japan K.K.
- Sojitz Corporation
Exhibition Sponsor
- Gilead Sciences K.K.
- Medicon Inc.
- GE HealthCare
- MITAKA KOHKI CO.,LTD
Advertising Sponsor
- Kansaimedicalnet Co.,Ltd.
- Nippon Boehringer Ingelheim Co., Ltd.
- ASTRAZENECA
- EP-Link Co., Ltd
- HOLOGIC JAPAN
- FUJIFILM Medical Co., Ltd.
Donation
- Quadrille Nishida
Organizing Committee
Graduate School of Medicine, Kyoto University
Kansai Medical University
Mie University Hospital
Organizing Committee
Preemptive Medicine and Lifestyle-related Disease Research Center
Kyoto University Hospital
Graduate School of Medicine, Kyoto University
Graduate School of Medicine, Kyoto University
Call for poster abstracts
Outstanding presentations will be recognized with awards and prizes💰
Brief description of the presentation submission period
Thu. December 18, 2025 - Mon. March 9th, 2026
Abstract Submission Process
First, please submit your presentation title together with a brief description (approximately 250 words).
Notification of acceptance will be sent around March 10th 2026.
If your abstract is accepted, you will then be asked to submit the full abstract (approximately 450 words).
Field / Topic
- Basic & Translational Breast Cancer Research
- Breast Cancer Biology, Genomics & Biomarkers
- Tumor Microenvironment & Immunology / Immunotherapy
- Hormone Receptor–Positive Breast Cancer
- HER2-Positive Breast Cancer
- Triple-Negative Breast Cancer (TNBC)
- Early & Locally Advanced Breast Cancer
- Metastatic / Advanced Breast Cancer
- Systemic Therapy (Chemotherapy, Targeted & Endocrine Therapy)
- Neoadjuvant & Adjuvant Therapy
- Breast Surgery & Reconstruction
- Radiation Oncology
- Imaging, Diagnostics, Pathology & Precision Medicine
- Clinical Trials & Real-World Evidence
- Survivorship, Supportive Care & Quality of Life
- Prevention, Genetics, Health Policy & Global Breast Cancer Care
- Other (please specify)